Berenberg Bank Reiterates “Buy” Rating for Victrex (VCT)
Victrex (LON:VCT)‘s stock had its “buy” rating restated by stock analysts at Berenberg Bank in a research report issued to clients and investors on Tuesday. They currently have a GBX 2,600 ($34.99) price objective on the stock. Berenberg Bank’s price objective points to a potential upside of 2.67% from the company’s current price.
VCT has been the topic of several other reports. Barclays lowered their price objective on shares of Victrex from GBX 2,350 ($31.63) to GBX 2,270 ($30.55) and set an “equal weight” rating on the stock in a research note on Tuesday, November 28th. J P Morgan Chase & Co boosted their price objective on shares of Victrex from GBX 2,150 ($28.94) to GBX 2,250 ($30.28) and gave the stock a “neutral” rating in a research note on Wednesday. Peel Hunt boosted their price objective on shares of Victrex from GBX 2,100 ($28.26) to GBX 2,300 ($30.96) and gave the stock an “add” rating in a research note on Tuesday, September 5th. Deutsche Bank restated a “hold” rating on shares of Victrex in a research note on Thursday, August 24th. Finally, Liberum Capital restated a “buy” rating and set a GBX 2,240 ($30.15) price objective on shares of Victrex in a research note on Monday, September 4th. Eight analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of GBX 2,248.91 ($30.27).
Shares of Victrex (LON:VCT) opened at GBX 2,532.33 ($34.08) on Tuesday. Victrex has a 52 week low of GBX 1,720 ($23.15) and a 52 week high of GBX 2,607 ($35.09).
ILLEGAL ACTIVITY NOTICE: This report was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another domain, it was illegally copied and reposted in violation of US & international copyright & trademark law. The correct version of this report can be accessed at https://www.thecerbatgem.com/2017/12/07/berenberg-bank-reiterates-buy-rating-for-victrex-vct.html.
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.
Receive News & Stock Ratings for Victrex plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex plc and related stocks with our FREE daily email newsletter.